234 related articles for article (PubMed ID: 10777191)
1. Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children.
Jeshion WC; Larsen KL; Jawad AF; Piccoli DA; Verma R; Maller ES; Baldassano RN
J Clin Gastroenterol; 2000 Apr; 30(3):294-8. PubMed ID: 10777191
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of response of perianal Crohn's disease to azathioprine or 6-mercaptopurine.
Lecomte T; Contou JF; Beaugerie L; Carbonnel F; Cattan S; Gendre JP; Cosnes J
Dis Colon Rectum; 2003 Nov; 46(11):1469-75. PubMed ID: 14605564
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease.
Dejaco C; Harrer M; Waldhoer T; Miehsler W; Vogelsang H; Reinisch W
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1113-20. PubMed ID: 14653831
[TBL] [Abstract][Full Text] [Related]
4. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
Ochsenkühn T; Göke B; Sackmann M
Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae.
Lowry PW; Weaver AL; Tremaine WJ; Sandborn WJ
Inflamm Bowel Dis; 1999 Nov; 5(4):239-45. PubMed ID: 10579116
[TBL] [Abstract][Full Text] [Related]
6. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
Schwartz DA; White CM; Wise PE; Herline AJ
Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
[TBL] [Abstract][Full Text] [Related]
7. Role of immunosuppressives in special situations: perianal disease and postoperative period.
Ghosh S; Iacucci M
Dig Dis; 2014; 32 Suppl 1():92-5. PubMed ID: 25531359
[TBL] [Abstract][Full Text] [Related]
8. Review article: The medical treatment of Crohn's perianal fistulas.
Schwartz DA; Herdman CR
Aliment Pharmacol Ther; 2004 May; 19(9):953-67. PubMed ID: 15113362
[TBL] [Abstract][Full Text] [Related]
9. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.
Hassard PV; Vasiliauskas EA; Kam LY; Targan SR; Abreu MT
Inflamm Bowel Dis; 2000 Feb; 6(1):16-20. PubMed ID: 10701145
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
[TBL] [Abstract][Full Text] [Related]
12. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin treatment of anal and perianal lesions associated with Crohn's disease.
Cat H; Sophani I; Lemann M; Modiglani R; Solue JC
Turk J Gastroenterol; 2003 Jun; 14(2):121-7. PubMed ID: 14614639
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
15. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
[TBL] [Abstract][Full Text] [Related]
16. Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
Chhaya V; Saxena S; Cecil E; Subramanian V; Curcin V; Majeed A; Pollok RC
Inflamm Bowel Dis; 2015 Feb; 21(2):385-91. PubMed ID: 25569740
[TBL] [Abstract][Full Text] [Related]
17. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Prefontaine E; Macdonald JK; Sutherland LR
Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
[TBL] [Abstract][Full Text] [Related]
18. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
[TBL] [Abstract][Full Text] [Related]
19. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
[TBL] [Abstract][Full Text] [Related]
20. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: pro.
Hyams JS
Inflamm Bowel Dis; 2005 Feb; 11(2):197-9. PubMed ID: 15677914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
